Barriers to successful implementation of the human papillomavirus vaccination exist.
However, there is limited evidence on implementation strategies in sub-Saharan Africa …

School-age youth constitute a neglected but highly vulnerable group concerning sexual
health risks in low-resource countries. Robust evidence concerning the research landscape …

Introduction The human papillomavirus (HPV) vaccination is an important preventive
measure for HPV-related conditions such as cervical cancer. In 2019, Zambia introduced a …

Parental consent for adolescent human papillomavirus (HPV) vaccine uptake is important;
however, refusal is prevalent. Therefore, this study aimed to understand factors associated …

Introduction Cervical cancer is the most common malignant tumor among women. It is the
main cause of death among women in sub-Saharan African countries. Particularly, the …

Introduction Human papillomavirus (HPV) infection is the most prevalent sexually
transmitted infection worldwide. HPV vaccination is an important tool to prevent and control …

Every clinical trial must be registered in a publicly accessible trial registry before enrollment
of the first participant. Prospectively registering clinical trials before enrolling participants …

The human papillomavirus (HPV) vaccine is effective in cervical cancer prevention.
However, many barriers to uptake exist and strategies to overcome them are needed …

Background Almost all cases of cervical and anal cancer have been linked to the human
papillomavirus (HPV). However, in addition to women who develop HPV-related cervical …

Cervical cancer can be prevented, primarily by the administration of the human
papillomavirus (HPV) vaccine. Healthcare workers (HCWs) and teachers play important …